rubidium has been researched along with Adverse Drug Event in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowlby, MR; Dunlop, J; Peri, R; Zhang, H | 1 |
| Hollister, LE | 1 |
2 review(s) available for rubidium and Adverse Drug Event
| Article | Year |
|---|---|
hERG (KCNH2 or Kv11.1) K+ channels: screening for cardiac arrhythmia risk.
Topics: Animals; Arrhythmias, Cardiac; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Electrophysiology; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Predictive Value of Tests; Radioligand Assay; Rubidium | 2008 |
Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.
Topics: Affective Symptoms; Behavior; Bipolar Disorder; Chlorpromazine; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Humans; Kinetics; Lithium; Mental Disorders; Pharmaceutical Preparations; Psychopharmacology; Psychotic Disorders; Rubidium; Schizophrenia; Terminology as Topic | 1972 |